The article discusses the challenges and opportunities in the clinical translation of mobile microrobotics for medical applications. It highlights the need for close collaboration between clinical experts and microrobotics researchers to address technical challenges in microfabrication, safety, and imaging. The "magic bullet" concept, introduced by Paul Ehrlich, has inspired the development of targeted therapies, and microrobotics offers a promising avenue to achieve precise and targeted medical treatments. Medical microrobotics involves the design and operation of microrobots at the cell-size scale for diagnostic and therapeutic purposes. These robots can be used in various biomedical applications, including medical imaging, cellular diagnosis, drug delivery, hyperthermia, immunotherapy, and neurostimulation. However, the clinical translation of microrobots faces significant challenges, including the need for precise control, material stability, and imaging constraints. The article outlines the current status of medical microrobotics, emphasizing the importance of rigorous validation and evaluation of microrobotic technologies to ensure their potential benefits are supported by scientific evidence and clinical feasibility. It also discusses the physical and biological constraints that microrobots must overcome to function effectively in the human body, including the complex fluid dynamics, tissue interactions, and immune system responses. The article concludes with a roadmap for the future development of medical microrobotics, emphasizing the need for interdisciplinary collaboration and further research to advance the field and achieve successful clinical applications.The article discusses the challenges and opportunities in the clinical translation of mobile microrobotics for medical applications. It highlights the need for close collaboration between clinical experts and microrobotics researchers to address technical challenges in microfabrication, safety, and imaging. The "magic bullet" concept, introduced by Paul Ehrlich, has inspired the development of targeted therapies, and microrobotics offers a promising avenue to achieve precise and targeted medical treatments. Medical microrobotics involves the design and operation of microrobots at the cell-size scale for diagnostic and therapeutic purposes. These robots can be used in various biomedical applications, including medical imaging, cellular diagnosis, drug delivery, hyperthermia, immunotherapy, and neurostimulation. However, the clinical translation of microrobots faces significant challenges, including the need for precise control, material stability, and imaging constraints. The article outlines the current status of medical microrobotics, emphasizing the importance of rigorous validation and evaluation of microrobotic technologies to ensure their potential benefits are supported by scientific evidence and clinical feasibility. It also discusses the physical and biological constraints that microrobots must overcome to function effectively in the human body, including the complex fluid dynamics, tissue interactions, and immune system responses. The article concludes with a roadmap for the future development of medical microrobotics, emphasizing the need for interdisciplinary collaboration and further research to advance the field and achieve successful clinical applications.